| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.09 |